Re: Bressler et al.: Factors associated with worsening proliferative diabetic retinopathy in eyes treated with panretinal photocoagulation or ranibizumab (Ophthalmology. 2017;124:431-439)

Merina Thomas; Rajesh C. Rao; Mark W. Johnson; Yannis M. Paulus

doi:10.1016/j.ophtha.2017.06.025

Re: Bressler et al.: Factors associated with worsening proliferative diabetic retinopathy in eyes treated with panretinal photocoagulation or ranibizumab (Ophthalmology. 2017;124:431-439)

Merina Thomas, Rajesh C. Rao, Mark W. Johnson, Yannis M. Paulus

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	e87-e88
Journal	Ophthalmology
Volume	124
Issue number	12
DOIs	https://doi.org/10.1016/j.ophtha.2017.06.025
State	Published - Dec 2017
Externally published	Yes

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1016/j.ophtha.2017.06.025

Cite this

Re: Bressler et al.: Factors associated with worsening proliferative diabetic retinopathy in eyes treated with panretinal photocoagulation or ranibizumab (Ophthalmology. 2017;124:431-439). / Thomas, Merina; Rao, Rajesh C.; Johnson, Mark W. et al.
In: Ophthalmology, Vol. 124, No. 12, 12.2017, p. e87-e88.

Research output: Contribution to journal › Letter › peer-review

@article{f3ba188e92964664ba608dd314b7b98f,

title = "Re: Bressler et al.: Factors associated with worsening proliferative diabetic retinopathy in eyes treated with panretinal photocoagulation or ranibizumab (Ophthalmology. 2017;124:431-439)",

author = "Merina Thomas and Rao, {Rajesh C.} and Johnson, {Mark W.} and Paulus, {Yannis M.}",

note = "Funding Information: Financial Disclosures: The authors made the following disclosure(s):Y.M.P. and R.C.R.: Funding – provided in part by the National Eye Institute Michigan Vision Clinician-Scientist Development Program 4K12EY022299, and National Eye Institute K08EY026654 (R.C.R.). ",

year = "2017",

month = dec,

doi = "10.1016/j.ophtha.2017.06.025",

language = "English (US)",

volume = "124",

pages = "e87--e88",

journal = "Ophthalmology",

issn = "0161-6420",

publisher = "Elsevier Inc.",

number = "12",

}

TY - JOUR

T1 - Re

T2 - Bressler et al.: Factors associated with worsening proliferative diabetic retinopathy in eyes treated with panretinal photocoagulation or ranibizumab (Ophthalmology. 2017;124:431-439)

AU - Thomas, Merina

AU - Rao, Rajesh C.

AU - Johnson, Mark W.

AU - Paulus, Yannis M.

N1 - Funding Information: Financial Disclosures: The authors made the following disclosure(s):Y.M.P. and R.C.R.: Funding – provided in part by the National Eye Institute Michigan Vision Clinician-Scientist Development Program 4K12EY022299, and National Eye Institute K08EY026654 (R.C.R.).

PY - 2017/12

Y1 - 2017/12

UR - http://www.scopus.com/inward/record.url?scp=85035815600&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035815600&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2017.06.025

DO - 10.1016/j.ophtha.2017.06.025

M3 - Letter

C2 - 29157435

AN - SCOPUS:85035815600

SN - 0161-6420

VL - 124

SP - e87-e88

JO - Ophthalmology

JF - Ophthalmology

IS - 12

ER -

Re: Bressler et al.: Factors associated with worsening proliferative diabetic retinopathy in eyes treated with panretinal photocoagulation or ranibizumab (Ophthalmology. 2017;124:431-439)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this